Genenta Science S.p.A. (GNTA)

Genenta Science Statistics

Total Valuation

Genenta Science has a market cap or net worth of $34.21 million. The enterprise value is $22.33 million.

Market Cap	34.21M
Enterprise Value	22.33M

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Genenta Science has 23.43 million shares outstanding. The number of shares has increased by 1.60% in one year.

Current Share Class	n/a
Shares Outstanding	23.43M
Shares Change (YoY)	+1.60%
Shares Change (QoQ)	+2.61%
Owned by Insiders (%)	21.47%
Owned by Institutions (%)	5.97%
Float	16.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.96
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.20, with a Debt / Equity ratio of 0.62.

Current Ratio	13.20
Quick Ratio	12.64
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.15% and return on invested capital (ROIC) is -29.55%.

Return on Equity (ROE)	-60.15%
Return on Assets (ROA)	-26.59%
Return on Invested Capital (ROIC)	-29.55%
Return on Capital Employed (ROCE)	-43.23%
Revenue Per Employee	n/a
Profits Per Employee	-$785,995
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.74% in the last 52 weeks. The beta is 0.57, so Genenta Science's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-70.74%
50-Day Moving Average	2.21
200-Day Moving Average	3.33
Relative Strength Index (RSI)	36.62
Average Volume (20 Days)	92,808

Short Selling Information

Short Interest	100,401
Short Previous Month	168,471
Short % of Shares Out	0.61%
Short % of Float	n/a
Short Ratio (days to cover)	0.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.13M
Pretax Income	-10.22M
Net Income	-10.22M
EBITDA	-10.09M
EBIT	-10.13M
Earnings Per Share (EPS)	-$0.55

Balance Sheet

The company has $20.75 million in cash and $8.87 million in debt, giving a net cash position of $11.88 million or $0.51 per share.

Cash & Cash Equivalents	20.75M
Total Debt	8.87M
Net Cash	11.88M
Net Cash Per Share	$0.51
Equity (Book Value)	14.23M
Book Value Per Share	0.74
Working Capital	22.79M

Cash Flow

In the last 12 months, operating cash flow was -$11.39 million and capital expenditures -$12,007, giving a free cash flow of -$11.43 million.

Operating Cash Flow	-11.39M
Capital Expenditures	-12,007
Free Cash Flow	-11.43M
FCF Per Share	-$0.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genenta Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.60%
Shareholder Yield	-1.60%
Earnings Yield	-29.87%
FCF Yield	-33.41%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1